Dr Reddy's Laboratories launches Ramelteon Tablets in US Market

23 Jul 2019 Evaluate

Dr. Reddy's Laboratories has launched Ramelteon Tablets, 8 mg, a therapeutically equivalent generic version of Rozerem (ramelteon, 8 mg) Tablets, approved by the U.S. Food and Drug Administration (USFDA).

The company’s Ramelteon Tablets, are available as 8 mg tablets in bottle count sizes of 30, 100, and 1000. According to IQVIA Health, the Rozerem brand had U.S. sales of approximately $91.3 million MAT for the most recent twelve months ending in May 2019.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1237.10 1.95 (0.16%)
27-Jan-2026 14:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1237.10
Cipla 1310.80
Zydus Lifesciences 892.40
Lupin 2133.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×